Chemotherapy

SEP 4, 2026 · OBSERVATIONAL STUDY

Evaluation of Thyroid Abnormity Incidence and Thyroid Toxicity During Chemotherapy Among Newly Diagnosed Breast Cancer

ClinicalTrials.gov

This is an active observational registry record with no reported results; it describes a planned study of thyroid toxicity during chemotherapy in breast cancer patients with estimated enrollment of 400.

AUG 17, 2026 · PHASE 2 TRIAL

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

ClinicalTrials.gov

This is a Phase 2 interventional trial registration with no results yet posted; it describes a planned study design and enrollment target only.

AUG 13, 2026 · OBSERVATIONAL STUDY

A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in Russia

ClinicalTrials.gov

This is a completed prospective observational registry study with no results posted; it describes treatment patterns and outcomes in routine practice but carries no efficacy or safety data in this record.

AUG 11, 2026 · PHASE 3 TRIAL

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

ClinicalTrials.gov

This is an active Phase 3 trial registration with no results posted; the study design is sound but outcome data are not yet available to assess efficacy or safety.

AUG 10, 2026 · JOURNAL ARTICLE

Cost-effectiveness analysis of finotonlimab in the treatment of advanced recurrent metastatic head and neck squamous cell carcinoma in China.

Human Vaccines & Immunotherapeutics

Modelling study based on a single trial's survival data, assessing cost-effectiveness in a specific healthcare system; does not itself evaluate clinical outcomes and depends on external trial evidence and assumptions.